Genomics In Cancer Care Market by Product and Application - Global Industry Analysis & Forecast to 2027
Published On : June 2022 Pages : 160 Category: Biotechnology Report Code : HC063961
Genomics In Cancer Care Market By Product (Instruments, Consumables, Services), and Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Research) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The DNA encased in the cell makes up our genome. Genomics is fundamentally an investigation of grouping of letters in the DNA and how each string exchanges data to help cells in the body framework to work appropriately. In cancer, minor changes in these hereditary letters can change the importance of what a genomic word implies. An adjustment in single letter can move the cell to make a protein that won't enable the cell to work appropriately. The investigation of malignancy genome has uncovered numerous variations from the norm in qualities that has driven the development of numerous different kinds of diseases.
Drivers and Restraints
Developing interest for diagnostics combined with accessibility of innovatively progressed and cost proficient indicative innovation is relied upon to fuel the market development in coming years. Rising interests in biotech and pharmaceutical industry and expanding R&D exercises for the improvement of novel treatments are the variables crediting towards the development of genomics in cancer growth care advertise. What's more, developing interest for customized prescription is relied upon to drive the interest over the conjecture time frame.
Regional Insights
Asia-Pacific is relied upon to enroll extensive development over the gauge time frame because of the prospering genomics market combined with the nearness of undiscovered chances, government backing and constantly creating human services framework.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Abbott Molecular
- Agilent Technologies
- Bio-Rad Labs
- Danaher Corporation
- Luminex
- Affymetrix and Illumina, Inc.
- Beckman Coulter, Inc.
- Cancer Genetics, Inc.
- General Electric Healthcare
- Oxford Gene Technology
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Genomics In Cancer Care Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Instruments
o Consumables
o Services
· Genomics In Cancer Care Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Diagnostics
o Personalized Medicine
o Drug Discovery & Development
o Research
· Genomics In Cancer Care Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott Molecular
o Agilent Technologies
o Bio-Rad Labs
o Danaher Corporation
o Luminex
o Affymetrix and Illumina, Inc.
o Beckman Coulter, Inc.
o Cancer Genetics, Inc.
o General Electric Healthcare
o Oxford Gene Technology
· Genomics In Cancer Care Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Genomics In Cancer Care Market, By Country
o U.S. Genomics In Cancer Care Market
o Canada Genomics In Cancer Care Market
o Mexico Genomics In Cancer Care Market
o Europe
§ Europe Genomics In Cancer Care Market, By Country
· Germany Genomics In Cancer Care Market
o UK Genomics In Cancer Care Market
o France Genomics In Cancer Care Market
o Russia Genomics In Cancer Care Market
o Italy Genomics In Cancer Care Market
o Rest of Europe Genomics In Cancer Care Market
o Asia-Pacific
§ Asia-Pacific Genomics In Cancer Care Market, By Country
o China Genomics In Cancer Care Market
o Japan Genomics In Cancer Care Market
o South Korea Genomics In Cancer Care Market
o India Genomics In Cancer Care Market
o Southeast Asia Genomics In Cancer Care Market
o Rest of Asia-Pacific Genomics In Cancer Care Market
o South America
§ South America Genomics In Cancer Care Market
o Brazil Genomics In Cancer Care Market
o Argentina Genomics In Cancer Care Market
o Columbia Genomics In Cancer Care Market
o Rest of South America Genomics In Cancer Care Market
o Middle East and Africa
§ Middle East and Africa Genomics In Cancer Care Market
o Saudi Arabia Genomics In Cancer Care Market
o UAE Genomics In Cancer Care Market
o Egypt Genomics In Cancer Care Market
o Nigeria Genomics In Cancer Care Market
o South Africa Genomics In Cancer Care Market
o Rest of MEA Genomics In Cancer Care Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Genomics In Cancer Care Market, By Product
5.1. Introduction
5.2. Global Genomics In Cancer Care Revenue and Market Share by Product (2017-2027)
5.2.1. Global Genomics In Cancer Care Revenue and Revenue Share by Product (2017-2027)
5.3. Instruments
5.3.1. Global Instruments Revenue and Growth Rate (2017-2027)
5.4. Consumables
5.4.1. Global Consumables Revenue and Growth Rate (2017-2027)
5.5. Services
5.5.1. Global Services Revenue and Growth Rate (2017-2027)
6. Genomics In Cancer Care Market, By Application
6.1. Introduction
6.2. Global Genomics In Cancer Care Revenue and Market Share by Application (2017-2027)
6.2.1. Global Genomics In Cancer Care Revenue and Revenue Share by Application (2017-2027)
6.3. Diagnostics
6.3.1. Global Diagnostics Revenue and Growth Rate (2017-2027)
6.4. Personalized Medicine
6.4.1. Global Personalized Medicine Revenue and Growth Rate (2017-2027)
6.5. Drug Discovery & Development
6.5.1. Global Drug Discovery & Development Revenue and Growth Rate (2017-2027)
6.6. Research
6.6.1. Global Research Revenue and Growth Rate (2017-2027)
7. Genomics In Cancer Care Market, By Region
7.1. Introduction
7.2. Global Genomics In Cancer Care Revenue and Market Share by Regions
7.2.1. Global Genomics In Cancer Care Revenue by Regions (2017-2027)
7.3. North America Genomics In Cancer Care by Countries
7.3.1. North America Genomics In Cancer Care Revenue and Growth Rate (2017-2027)
7.3.2. North America Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Genomics In Cancer Care by Countries
7.4.1. Europe Genomics In Cancer Care Revenue and Growth Rate (2017-2027)
7.4.2. Europe Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Genomics In Cancer Care by Countries
7.5.1. Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Genomics In Cancer Care by Countries
7.6.1. South America Genomics In Cancer Care Revenue and Growth Rate (2017-2027)
7.6.2. South America Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Genomics In Cancer Care by Countries
7.7.1. Middle East and Africa Genomics In Cancer Care Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Abbott Molecular
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Agilent Technologies
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Bio-Rad Labs
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Danaher Corporation
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Luminex
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Affymetrix and Illumina, Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Beckman Coulter, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Cancer Genetics, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. General Electric Healthcare
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Oxford Gene Technology
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
8.11. Honeywell International
8.11.1. Business Overview
8.11.2. Service Portfolio
8.11.3. Strategic Developments
8.11.4. Financial Overview
9. Genomics In Cancer Care Market Forecast (2017-2027)
9.1. Global Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Genomics In Cancer Care Market Forecast by Regions (2017-2027)
9.2.1. North America Genomics In Cancer Care Market Forecast (2017-2027)
9.2.1.1. United States Genomics In Cancer Care Market Forecast (2017-2027)
9.2.1.2. Canada Genomics In Cancer Care Market Forecast (2017-2027)
9.2.1.3. Mexico Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2. Europe Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2.1. Germany Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2.2. France Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2.3. UK Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2.4. Russia Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2.5. Italy Genomics In Cancer Care Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3. Asia-Pacific Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3.1. China Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3.2. Japan Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3.3. Korea Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3.4. India Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Genomics In Cancer Care Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Genomics In Cancer Care Market Forecast (2017-2027)
9.2.4. South America Genomics In Cancer Care Market Forecast (2017-2027)
9.2.4.1. Brazil Genomics In Cancer Care Market Forecast (2017-2027)
9.2.4.2. Argentina Genomics In Cancer Care Market Forecast (2017-2027)
9.2.4.3. Columbia Genomics In Cancer Care Market Forecast (2017-2027)
9.2.4.4. Rest of South America Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5. Middle East and Africa Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.3. Egypt Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.4. Nigeria Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.5. South Africa Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.6. Turkey Genomics In Cancer Care Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Genomics In Cancer Care Market Forecast (2017-2027)
9.3. Genomics In Cancer Care Market Forecast by Product (2017-2027)
9.3.1. Genomics In Cancer Care Forecast by Product (2017-2027)
9.3.2. Genomics In Cancer Care Market Share Forecast by Product (2017-2027)
9.4. Genomics In Cancer Care Market Forecast by Application (2017-2027)
9.4.1. Genomics In Cancer Care Forecast by Application (2017-2027)
9.4.2. Genomics In Cancer Care Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Genomics In Cancer Care Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Genomics In Cancer Care Revenue and Revenue Share by Product (2017-2018)
Figure Global Instruments Revenue and Growth Rate (2017-2018)
Figure Global Consumables Revenue and Growth Rate (2017-2018)
Figure Global Services Revenue and Growth Rate (2017-2018)
Table Global Genomics In Cancer Care Revenue and Revenue Share by Application (2017-2018)
Figure Global Diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Personalized Medicine Revenue and Growth Rate (2017-2018)
Figure Global Drug Discovery & Development Revenue and Growth Rate (2017-2018)
Figure Global Research Revenue and Growth Rate (2017-2018)
Table Global Genomics In Cancer Care Revenue by Regions (2017-2018)
Figure North America Genomics In Cancer Care Growth Rate (2017-2018)
Figure North America Genomics In Cancer Care Revenue and Growth Rate (2017-2018)
Figure North America Genomics In Cancer Care by Countries (2017-2018)
Figure North America Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2018)
Figure United States Genomics In Cancer Care Growth Rate (2017-2018)
Figure United States Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Genomics In Cancer Care Growth Rate (2017-2018)
Figure Canada Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Genomics In Cancer Care Growth Rate (2017-2018)
Figure Mexico Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Genomics In Cancer Care Growth Rate (2017-2018)
Figure Europe Genomics In Cancer Care Revenue and Growth Rate (2017-2018)
Figure Europe Genomics In Cancer Care by Countries (2017-2018)
Figure Europe Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2018)
Figure Germany Genomics In Cancer Care Growth Rate (2017-2018)
Figure Germany Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Genomics In Cancer Care Growth Rate (2017-2018)
Figure France Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Genomics In Cancer Care Growth Rate (2017-2018)
Figure UK Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Genomics In Cancer Care Growth Rate (2017-2018)
Figure Russia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Genomics In Cancer Care Growth Rate (2017-2018)
Figure Italy Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Genomics In Cancer Care Growth Rate (2017-2018)
Figure Rest of Europe Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Genomics In Cancer Care Growth Rate (2017-2018)
Figure Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Genomics In Cancer Care by Countries (2017-2018)
Figure Asia-Pacific Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2018)
Figure China Genomics In Cancer Care Growth Rate (2017-2018)
Figure China Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Genomics In Cancer Care Growth Rate (2017-2018)
Figure Japan Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Genomics In Cancer Care Growth Rate (2017-2018)
Figure Korea Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Genomics In Cancer Care Growth Rate (2017-2018)
Figure India Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Genomics In Cancer Care Growth Rate (2017-2018)
Figure Southeast Asia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Genomics In Cancer Care Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Genomics In Cancer Care Growth Rate (2017-2018)
Figure South America Genomics In Cancer Care Revenue and Growth Rate (2017-2018)
Figure South America Genomics In Cancer Care by Countries (2017-2018)
Figure South America Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Genomics In Cancer Care Growth Rate (2017-2018)
Figure Brazil Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Genomics In Cancer Care Growth Rate (2017-2018)
Figure Argentina Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Genomics In Cancer Care Growth Rate (2017-2018)
Figure Columbia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Genomics In Cancer Care Growth Rate (2017-2018)
Figure Rest of South America Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Genomics In Cancer Care Growth Rate (2017-2018)
Figure Middle East and Africa Genomics In Cancer Care Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Genomics In Cancer Care by Countries (2017-2018)
Figure Middle East and Africa Genomics In Cancer Care Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Genomics In Cancer Care Growth Rate (2017-2018)
Figure Saudi Arabia Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Genomics In Cancer Care Growth Rate (2017-2018)
Figure United Arab Emirates Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Genomics In Cancer Care Growth Rate (2017-2018)
Figure Egypt Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Genomics In Cancer Care Growth Rate (2017-2018)
Figure Nigeria Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Genomics In Cancer Care Growth Rate (2017-2018)
Figure South Africa Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Genomics In Cancer Care Growth Rate (2017-2018)
Figure Turkey Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Genomics In Cancer Care Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2017-2018)
Table Abbott Molecular Genomics In Cancer Care Financial Overview
Table Agilent Technologies Genomics In Cancer Care Financial Overview
Table Bio-Rad Labs Genomics In Cancer Care Financial Overview
Table Danaher Corporation Genomics In Cancer Care Financial Overview
Table Luminex Genomics In Cancer Care Financial Overview
Table Affymetrix and Illumina, Inc. Genomics In Cancer Care Financial Overview
Table Beckman Coulter, Inc. Genomics In Cancer Care Financial Overview
Table Cancer Genetics, Inc. Genomics In Cancer Care Financial Overview
Table General Electric Healthcare Genomics In Cancer Care Financial Overview
Table Oxford Gene Technology Genomics In Cancer Care Financial Overview
Table Honeywell International Genomics In Cancer Care Financial Overview
Figure Global Genomics In Cancer Care Revenue (Millions USD) and Growth Rate (2018-2025)
Table Genomics In Cancer Care Market Forecast by Regions (2018-2025)
Figure North America Genomics In Cancer Care Market Forecast (2018-2025)
Figure United States Genomics In Cancer Care Market Forecast (2018-2025)
Figure Canada Genomics In Cancer Care Market Forecast (2018-2025)
Figure Mexico Genomics In Cancer Care Market Forecast (2018-2025)
Figure Europe Genomics In Cancer Care Market Forecast (2018-2025)
Figure Germany Genomics In Cancer Care Market Forecast (2018-2025)
Figure France Genomics In Cancer Care Market Forecast (2018-2025)
Figure UK Genomics In Cancer Care Market Forecast (2018-2025)
Figure Russia Genomics In Cancer Care Market Forecast (2018-2025)
Figure Italy Genomics In Cancer Care Market Forecast (2018-2025)
Figure Rest of Europe Genomics In Cancer Care Market Forecast (2018-2025)
Figure Asia-Pacific Genomics In Cancer Care Market Forecast (2018-2025)
Figure China Genomics In Cancer Care Market Forecast (2018-2025)
Figure Japan Genomics In Cancer Care Market Forecast (2018-2025)
Figure Korea Genomics In Cancer Care Market Forecast (2018-2025)
Figure India Genomics In Cancer Care Market Forecast (2018-2025)
Figure Southeast Asia Genomics In Cancer Care Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Genomics In Cancer Care Market Forecast (2018-2025)
Figure South America Genomics In Cancer Care Market Forecast (2018-2025)
Figure Brazil Genomics In Cancer Care Market Forecast (2018-2025)
Figure Argentina Genomics In Cancer Care Market Forecast (2018-2025)
Figure Columbia Genomics In Cancer Care Market Forecast (2018-2025)
Figure Rest of South America Genomics In Cancer Care Market Forecast (2018-2025)
Figure Middle East and Africa Genomics In Cancer Care Market Forecast (2018-2025)
Figure Saudi Arabia Genomics In Cancer Care Market Forecast (2018-2025)
Figure United Arab Emirates Genomics In Cancer Care Market Forecast (2018-2025)
Figure Egypt Genomics In Cancer Care Market Forecast (2018-2025)
Figure Nigeria Genomics In Cancer Care Market Forecast (2018-2025)
Figure South Africa Genomics In Cancer Care Market Forecast (2018-2025)
Figure Turkey Genomics In Cancer Care Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Genomics In Cancer Care Market Forecast (2018-2025)
Figure Global Genomics In Cancer Care Forecast by Product (2018-2025)
Figure Global Genomics In Cancer Care Market Share Forecast by Product (2018-2025)
Figure Global Genomics In Cancer Care Forecast by Product (2018-2025)
Figure Global Genomics In Cancer Care Forecast by Application (2018-2025)
Figure Global Genomics In Cancer Care Market Share Forecast by Application (2018-2025)
Figure Global Genomics In Cancer Care Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|